These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

791 related items for PubMed ID: 17903340

  • 1. The -675 4G/5G polymorphism at the Plasminogen Activator Inhibitor 1 (PAI-1) gene modulates plasma Plasminogen Activator Inhibitor 1 concentrations in response to dietary fat consumption.
    Pérez-Martínez P, Adarraga-Cansino MD, Fernández de la Puebla RA, Blanco-Molina A, Delgado-Lista J, Marín C, Ordovás JM, López-Miranda J, Pérez-Jiménez F.
    Br J Nutr; 2008 Apr; 99(4):699-702. PubMed ID: 17903340
    [Abstract] [Full Text] [Related]

  • 2. The effect of apoE genotype and sex on ApoE plasma concentration is determined by dietary fat in healthy subjects.
    Moreno JA, Pérez-Jiménez F, Moreno-Luna R, Pérez-Martínez P, Fuentes-Jiménez F, Marín C, Portugal H, Lairon D, López-Miranda J.
    Br J Nutr; 2009 Jun; 101(12):1745-52. PubMed ID: 19025720
    [Abstract] [Full Text] [Related]

  • 3. The APOB -516C/T polymorphism has no effect on lipid and apolipoprotein response following changes in dietary fat intake in a healthy population.
    Perez-Martinez P, Perez-Jimenez F, Ordovas JM, Bellido C, Moreno JA, Gomez P, Marin C, Fernandez de la Puebla RA, Paniagua JA, Lopez-Miranda J.
    Nutr Metab Cardiovasc Dis; 2007 Mar; 17(3):224-9. PubMed ID: 17367707
    [Abstract] [Full Text] [Related]

  • 4. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT, Wiman B, Vettore S, Dazzi F, Girolami A, Patrassi GM.
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [Abstract] [Full Text] [Related]

  • 5. The effect of plasminogen activator inhibitor-1 gene 4G/5G polymorphism on glucose and lipid metabolisms in Turkish obese children.
    Kinik ST, Ataç FB, Verdi H, Cetintaş S, Sahin FI, Ozbek N.
    Clin Endocrinol (Oxf); 2005 May; 62(5):607-10. PubMed ID: 15853833
    [Abstract] [Full Text] [Related]

  • 6. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
    Stegnar M, Uhrin P, Peternel P, Mavri A, Salobir-Pajnic B, Stare J, Binder BR.
    Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
    [Abstract] [Full Text] [Related]

  • 7. Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels.
    Matsubara Y, Murata M, Isshiki I, Watanabe R, Zama T, Watanabe G, Watanabe K, Ikeda Y.
    Int J Hematol; 1999 Jan; 69(1):43-7. PubMed ID: 10641442
    [Abstract] [Full Text] [Related]

  • 8. PAI-1 Gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample.
    Meigs JB, Dupuis J, Liu C, O'Donnell CJ, Fox CS, Kathiresan S, Gabriel SB, Larson MG, Yang Q, Herbert AG, Wilson PW, Feng D, Tofler GH, Cupples LA.
    Obesity (Silver Spring); 2006 May; 14(5):753-8. PubMed ID: 16855181
    [Abstract] [Full Text] [Related]

  • 9. The APOB -516C/T polymorphism is associated with differences in insulin sensitivity in healthy males during the consumption of diets with different fat content.
    Pérez-Martínez P, Pérez-Jiménez F, Ordovás JM, Moreno JA, Moreno R, Fuentes F, Ruano J, Gómez P, Marín C, López-Miranda J.
    Br J Nutr; 2007 Apr; 97(4):622-7. PubMed ID: 17349073
    [Abstract] [Full Text] [Related]

  • 10. The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de I'nfarctus du Mycocarde.
    Ye S, Green FR, Scarabin PY, Nicaud V, Bara L, Dawson SJ, Humphries SE, Evans A, Luc G, Cambou JP.
    Thromb Haemost; 1995 Sep; 74(3):837-41. PubMed ID: 8571307
    [Abstract] [Full Text] [Related]

  • 11. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
    Jorgenson E, Deitcher SR, Cicek M, Liu X, Plummer S, Casey G, Witte JS.
    Prostate; 2007 Feb 01; 67(2):172-7. PubMed ID: 17044080
    [Abstract] [Full Text] [Related]

  • 12. Postoperative bleeding in cardiac surgery: the role of tranexamic acid in patients homozygous for the 5G polymorphism of the plasminogen activator inhibitor-1 gene.
    Iribarren JL, Jimenez JJ, Hernández D, Brouard M, Riverol D, Lorente L, de La Llana R, Nassar I, Perez R, Martinez R, Mora ML.
    Anesthesiology; 2008 Apr 01; 108(4):596-602. PubMed ID: 18362590
    [Abstract] [Full Text] [Related]

  • 13. Association of plasminogen activator inhibitor-1 4G/5G gene polymorphism with variations in the LDL particle size in healthy Japanese men.
    Kitamura Y, Okumura K, Imamura A, Mizuno T, Tsuzuki M, Numaguchi Y, Matsui H, Murohara T.
    Clin Chim Acta; 2004 Sep 01; 347(1-2):209-16. PubMed ID: 15313160
    [Abstract] [Full Text] [Related]

  • 14. Interaction between smoking and the Sstl polymorphism of the apo C-III gene determines plasma lipid response to diet.
    Pérez-Martínez P, Gómez P, Paz E, Marín C, Gavilán Moral E, López-Miranda J, Ordovas JM, Fernandez de la Puebla RA, Pérez-Jiménez F.
    Nutr Metab Cardiovasc Dis; 2001 Aug 01; 11(4):237-43. PubMed ID: 11837227
    [Abstract] [Full Text] [Related]

  • 15. Influence of the 4G/5G PAI-1 genotype on angiotensin II-stimulated human endothelial cells and in patients with hypertension.
    Roncal C, Orbe J, Rodriguez JA, Belzunce M, Beloqui O, Diez J, Páramo JA.
    Cardiovasc Res; 2004 Jul 01; 63(1):176-85. PubMed ID: 15194475
    [Abstract] [Full Text] [Related]

  • 16. Role of the 4G/5G polymorphism of PaI-1 gene promoter on PaI-1 levels in obese patients: influence of fat distribution and insulin-resistance.
    Sartori MT, Vettor R, De Pergola G, De Mitrio V, Saggiorato G, Della Mea P, Patrassi GM, Lombardi AM, Fabris R, Girolami A.
    Thromb Haemost; 2001 Nov 01; 86(5):1161-9. PubMed ID: 11816701
    [Abstract] [Full Text] [Related]

  • 17. Effect of 4G/5G PAI-1 polymorphism on the response of PAI-1 activity to vitamin E supplementation in Type 2 diabetic patients.
    Testa R, Bonfigli AR, Sirolla C, Boemi M, Manfrini S, Mari D, Testa I, Sacchi E, Franceschi C.
    Diabetes Nutr Metab; 2004 Aug 01; 17(4):217-21. PubMed ID: 15575342
    [Abstract] [Full Text] [Related]

  • 18. [The influences of genetic and environmental factors on plasma plasminogen activator inhibitor-1 levels in patients with essential hypertension].
    Song Y, Xu W, Chen Y, Che L, Wang Q, Zhou X, Wu J.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Dec 01; 16(6):374-6. PubMed ID: 10581347
    [Abstract] [Full Text] [Related]

  • 19. Plasma PAI-1 levels in obese children--effect of weight loss and influence of PAI-1 promoter 4G/5G genotype.
    Estellés A, Dalmau J, Falcó C, Berbel O, Castelló R, España F, Aznar J.
    Thromb Haemost; 2001 Aug 01; 86(2):647-52. PubMed ID: 11522017
    [Abstract] [Full Text] [Related]

  • 20. A monounsaturated fatty acid-rich diet reduces macrophage uptake of plasma oxidised low-density lipoprotein in healthy young men.
    Moreno JA, López-Miranda J, Pérez-Martínez P, Marín C, Moreno R, Gómez P, Paniagua JA, Pérez-Jiménez F.
    Br J Nutr; 2008 Sep 01; 100(3):569-75. PubMed ID: 18226292
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.